Press Releases

Date	Title	Company
23-Mar-2026	Wellgistics Health Inc. Signs $105,000,000 Letter of Intent to Evaluate Potential Acquisition of Neuritek Therapeutics, Inc. which is Pioneering Innovative Therapies for Neurological and Psychiatric Disorders	ACCESS Newswire
23-Mar-2026	Medical Component Specialists Expands Global Footprint with New State-of-the-Art Manufacturing Facility in Costa Rica	ACCESS Newswire
23-Mar-2026	MIRA Pharmaceuticals Reports Mira-55 Shows No THC- or Rimonabant-Associated CNS Side Effects in Preclinical Studies	ACCESS Newswire
23-Mar-2026	Med-X to Showcase Nature-Cide at AMCA's 92nd Annual Meeting	ACCESS Newswire
23-Mar-2026	OSR Holdings Updates $815 Million VXM01 Licensing Deal Structure to Capture Value at Parent Level	ACCESS Newswire
23-Mar-2026	DNP Establishes Second Overseas R&D Base in IIT Hyderabad, India	Businesswire
21-Mar-2026	Prothena Partners Present Data Supporting Next Generation Treatments for Parkinson’s and Alzheimer’s Disease at AD/PD™ 2026	Businesswire
21-Mar-2026	Omeros Announces Upcoming Presentation at EBMT 2026 Highlighting Advances in TA-TMA Treatment	Businesswire
20-Mar-2026	Bristol Myers Squibb Transforms the Classical Hodgkin Lymphoma Treatment Paradigm with Expanded U.S. and EMA Approvals for Opdivo® (nivolumab)	Businesswire
20-Mar-2026	Robbins LLP Reminds Inovio Pharmaceuticals, Inc. Stockholders of the Pending Class Action Against INO and Urges Harmed Stockholders to Seek More Information	Businesswire
20-Mar-2026	ImmunityBio Announces Approval in Macau SAR, China for ANKTIVA® in BCG-Unresponsive NMIBC with CIS ± Papillary Tumors	Businesswire
20-Mar-2026	pSemi, a Murata Company, Unveils Breakthrough Power Solutions for Fast‑Charging Mobile Devices and Next‑Generation Humanoid Robotics at APEC 2026	Businesswire
20-Mar-2026	NHS Scotland takes ‘world-leading step’ in further reducing healthcare emissions across the country	InnoScot Health
20-Mar-2026	Tivic To Report 2025 Year-End Financial Results Via Conference Call and Webcast on March 25th at 1:30pm PT / 4:30pm ET	ACCESS Newswire
20-Mar-2026	Qiagen Announces Form 20-F Annual Report Filing for 2025 Results	Businesswire
20-Mar-2026	Not All CBD Is Medicine: Why Medicare's Plan Could Undermine FDA Marijuana Science	ACCESS Newswire
20-Mar-2026	KalVista Pharmaceuticals to Present New EKTERLY® (sebetralstat) Data at the 2026 Global Angioedema Leadership Conference	Businesswire
20-Mar-2026	First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)	Businesswire
20-Mar-2026	Avel eCare Calls for Virtual Health Integration in State Rural Health Transformation Strategies	ACCESS Newswire
20-Mar-2026	Novartis to Acquire Synnovation Therapeutics’ Pan-Mutant Selective PI3Kα Inhibitor Program	Businesswire